BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29852276)

  • 1. Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination.
    Ndaw S; Hanser O; Kenepekian V; Vidal M; Melczer M; Remy A; Robert A; Bakrin N
    Toxicol Lett; 2018 Dec; 298():171-176. PubMed ID: 29852276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?
    Ametsbichler P; Böhlandt A; Nowak D; Schierl R
    Eur J Surg Oncol; 2018 Nov; 44(11):1793-1799. PubMed ID: 29871821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy.
    Larroque M; Arnaudguilhem C; Bouyssiere B; Quenet F; Bouazza N; Jarlier M; Boulabas S; Mounicou S; Sgarbura O
    Toxicol Appl Pharmacol; 2021 Oct; 429():115694. PubMed ID: 34428445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure.
    Konate A; Poupon J; Villa A; Garnier R; Hasni-Pichard H; Mezzaroba D; Fernandez G; Pocard M
    J Surg Oncol; 2011 Jan; 103(1):6-9. PubMed ID: 20886552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC).
    Schierl R; Novotna J; Piso P; Böhlandt A; Nowak D
    Eur J Surg Oncol; 2012 Jan; 38(1):88-94. PubMed ID: 22035874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC).
    Villa AF; El Balkhi S; Aboura R; Sageot H; Hasni-Pichard H; Pocard M; Elias D; Joly N; Payen D; Blot F; Poupon J; Garnier R
    Ind Health; 2015; 53(1):28-37. PubMed ID: 25327298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contamination risk for operators performing semi-closed HIPEC procedure using cisplatin.
    Caneparo A; Massucco P; Vaira M; Maina G; Giovale E; Coggiola M; Cinquegrana A; Robella M; De Simone M
    Eur J Surg Oncol; 2014 Aug; 40(8):925-9. PubMed ID: 24726786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is hyperthermic intraperitoneal chemotherapy (HIPEC) safe for healthcare workers?
    Rodier S; Saint-Lorant G; Guilloit JM; Palix A; Divanon F; Sichel F; Delépée R
    Surg Oncol; 2017 Sep; 26(3):242-251. PubMed ID: 28807243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the risk of contamination of surgical personnel by vaporization of oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC).
    Guerbet M; Goullé JP; Lubrano J
    Eur J Surg Oncol; 2007 Jun; 33(5):623-6. PubMed ID: 17408909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental and biological monitoring on an oncology ward during a complete working week.
    Koller M; Böhlandt A; Haberl C; Nowak D; Schierl R
    Toxicol Lett; 2018 Dec; 298():158-163. PubMed ID: 29738807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures].
    Jansen-Winkeln B; Thieme R; Haase L; Niebisch S; Pommer C; Lyros O; Zimmer J; Lordick F; Remane Y; Frontini R; Gockel I
    Chirurg; 2019 Feb; 90(2):137-145. PubMed ID: 29947920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Kyriazanos I; Kalles V; Stefanopoulos A; Spiliotis J; Mohamed F
    Surg Oncol; 2016 Sep; 25(3):308-14. PubMed ID: 27566037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin and oxaliplatin surface contamination in intensive care units (ICUs) and hospital wards during attendance of HIPEC patients.
    Schenk KE; Schierl R; Angele M; Burkhart-Reichl A; Glockzin G; Novotny A; Nowak D
    Int Arch Occup Environ Health; 2016 Aug; 89(6):991-6. PubMed ID: 27142971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells.
    Khosrawipour V; Diaz-Carballo D; Acikelli AH; Khosrawipour T; Falkenstein TA; Wu D; Zieren J; Giger-Pabst U
    World J Surg Oncol; 2017 Feb; 15(1):43. PubMed ID: 28183319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy.
    Roussin F; Taibi A; Canal-Raffin M; Cantournet L; Durand-Fontanier S; Druet-Cabanac M; El Balkhi S; Maillan G
    Eur J Surg Oncol; 2021 Nov; 47(11):2939-2947. PubMed ID: 34034944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in an operating room without laminar airflow.
    Delhorme JB; Klipfel A; D'Antonio F; Greget MC; Diemunsch P; Rohr S; Romain B; Brigand C
    J Visc Surg; 2019 Dec; 156(6):485-488. PubMed ID: 31296454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PIPAC--Pressurized intraperitoneal aerosol chemotherapy. A novel treatment for peritoneal carcinomatosis].
    Hübner M; Teixeira H; Boussaha T; Cachemaille M; Lehmann K; Demartines N
    Rev Med Suisse; 2015 Jun; 11(479):1325-30. PubMed ID: 26255492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model.
    Jung W; Park M; Park SJ; Lee EJ; Kim HS; Chung SH; Yoon C
    Saf Health Work; 2023 Jun; 14(2):237-242. PubMed ID: 37389318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental safety during the administration of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC).
    Graversen M; Pedersen PB; Mortensen MB
    Pleura Peritoneum; 2016 Dec; 1(4):203-208. PubMed ID: 30911624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.